A Phase 1, First-In-Human, Dose-Seeking Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2017
At a glance
- Drugs MPT 0E028 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Jun 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2018.
- 01 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 18 Mar 2016 New trial record